The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: Two-year follow-up
Abstract
PURPOSE: To assess the long-term safety and efficacy of a single trabecular micro-bypass stent with concomitant cataract surgery versus cataract surgery alone for mild to moderate open-angle glaucoma. SETTING: Twenty-nine investigational sites, United States. DESIGN: Prospective randomized controlled multicenter clinical trial. METHODS: Eyes with mild to moderate glaucoma with an unmedicated intraocular pressure (IOP) of 22 mm Hg or higher and 36 mm Hg or lower were randomly assigned to have cataract surgery with iStent trabecular micro-bypass stent implantation (stent group) or cataract surgery alone (control group). Patients were followed for 24 months postoperatively. RESULTS: The incidence of adverse events was low in both groups through 24 months of follow-up. At 24 months, the proportion of patients with an IOP of 21 mm Hg or lower without ocular hypotensive medications was significantly higher in the stent group than in the control group (P=.036). Overall, the mean IOP was stable between 12 months and 24 months (17.0 mm Hg ± 2.8 [SD] and 17.1 ± 2.9 mm Hg, respectively) in the stent group but increased (17.0 ± 3.1 mm Hg to 17.8 ± 3.3 mm Hg, respectively) in the control group. Ocular hypotensive medication was statistically significantly lower in the stent group at 12 months; it was also lower at 24 months, although the difference was no longer statistically significant. CONCLUSIONS: Patients with combined single trabecular micro-bypass stent and cataract surgery had significantly better IOP control on no medication through 24 months than patients having cataract surgery alone. Both groups had a similar favorable long-term safety profile. FINANCIAL DISCLOSURE: Dr. Craven was an investigator in the clinical trial of the iStent. Dr. Katz is a consultant to Glaukos and was the medical monitor for the clinical trial of the iStent. Dr. Katz is a stockholder in Glaukos. Mr. Wells and Ms. Giamporcaro are employees of Glaukos.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quigley, H. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61423-7 · Cited by 1,121
The Ocular Hypertension Treatment Study: Design and Baseline Description of the Participants
Gordon, M. O. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.5.573 · Cited by 441
Three-Year Follow-up of the Tube Versus Trabeculectomy Study
Gedde, S. J., Schiffman, J. C., Feuer, W. J., Herndon, L. W., Brandt, J. D., & Budenz, D. L. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.06.018 · Cited by 380
The Ocular Hypertension Treatment Study
Kass, M. A. (1994) · Journal of Glaucoma · doi:10.1097/00061198-199400320-00001 · Cited by 368
Adherence in Glaucoma: Objective Measurements of Once-Daily and Adjunctive Medication Use
Robin, A. L., Novack, G. D., Covert, D. W., Crockett, R. S., & Marcic, T. S. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.06.012 · Cited by 328
An Objective Evaluation of Eyedrop Instillation in Patients With Glaucoma
Stone, J. L. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.96 · Cited by 230
Compliance With Topical Timolol Treatment
Kass, M. A., Gordon, M., Morley, R. E., Meltzer, D. W., & Goldberg, J. J. (1987) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)74225-4 · Cited by 212
Multicenter study of compliance and drop administration in glaucoma
Kholdebarin, R., Campbell, R. J., Jin, Y.-P., & Buys, Y. M. (2008) · Canadian Journal of Ophthalmology · doi:10.3129/i08-076 · Cited by 194
Baudouin, C., Liang, H., Hamard, P., Riancho, L., Creuzot-Garcher, C., Warnet, J.-M., & Brignole-Baudouin, F. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.01.036 · Cited by 193
Cited by
Primary Open-Angle Glaucoma Preferred Practice Pattern®
Gedde, S. J., Vinod, K., Wright, M. M., Muir, K. W., Lind, J. T., Chen, P. P., Li, T., & Mansberger, S. L. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.10.022 · Cited by 474
Lavia, C., Dallorto, L., Maule, M., Ceccarelli, M., & Fea, A. M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183142 · Cited by 455
Graefe's Archive for Clinical and Experimental Ophthalmology
(2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/417.1435-702x · Cited by 399
Glaucoma treatment trends: a review
Conlon, R., Saheb, H., & Ahmed, I. I. K. (2017) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2016.07.013 · Cited by 344
Samuelson, T. W., Sarkisian, S. R., Lubeck, D. M., Stiles, M. C., Duh, Y.-J., Romo, E. A., Giamporcaro, J. E., Hornbeak, D. M., Katz, L. J., Bartlett, W., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2019.03.006 · Cited by 307
Self-citation
Metadata
- Authors
- Craven, R. E., Katz, J. L., Wells, J. M., & Giamporcaro, J. E.
- Venue
- Journal of Cataract and Refractive Surgery
- Published
- 2012-08
- Volume
- 38
- Issue
- 8
- Pages
- 1339-1345
- ISSN
- 0146-2776 (ISSN-L)
- 0886-3350
- OpenAlex
- W2027199310
- Cited by
- 344
- References
- 9
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.